DTILPrecision BioSciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 14440
Ticker: DTIL
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2019-03-28
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: DTIL

Detail

Enriched 2026-08-14 20:47

Market cap: $204,803,530.68
Shares outstanding (class): 27,601,554
Shares outstanding (weighted): 27,601,554
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 67
Location: DURHAM, NC
Homepage: https://www.precisionbiosciences.com
Description: Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Market cap and share counts drift.

Funds holding this security

10 funds · 12 positions · $18.62M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
abrdn World Healthcare Fund —	—	$6.29M	1.31%	1,144,208 NS	FIGI
abrdn Life Sciences Investors —	—	$5.97M	1.07%	1,085,970 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$3.46M	0.00%	629,339 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$1.46M	0.00%	264,945 NS	FIGI
Meridian Contrarian Fund Meridian Fund Inc	—	$985.3K	0.17%	179,140 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$287.4K	0.02%	52,256 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$66.0K	0.00%	12,004 NS	FIGI
Small Cap Core Fund Northern Funds	—	$40.7K	0.01%	7,395 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$24.5K	0.00%	4,452 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$19.9K	0.01%	3,613 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$12.2K	0.00%	2,219 NS	FIGI
Diversified Equity Master Portfolio Master Investment Portfolio	—	$2.1K	0.00%	387 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERDTIL
FIGI_COMPOSITEBBG008NSBPV3
FIGI_SHARE_CLASSBBG008NSBPW2
CIK0001357874
ISINUS74019P2074
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Precision BioSciences is a biotech company developing gene editing therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.